2022年(nian)版(ban)醫保藥(yao)(yao)品目(mu)錄顯示,目(mu)前中(zhong)國共收載(zai)西藥(yao)(yao)和中(zhong)成藥(yao)(yao)達2967種(zhong)(zhong),其中(zhong)西藥(yao)(yao)1586種(zhong)(zhong),中(zhong)成藥(yao)(yao)1381種(zhong)(zhong)。中(zhong)藥(yao)(yao)飲片未作調整,仍為(wei)892種(zhong)(zhong)。此(ci)次共111個(ge)(ge)藥(yao)(yao)品新增進入目(mu)錄,3個(ge)(ge)藥(yao)(yao)品被(bei)調出目(mu)錄。
本次調整(zheng)新增的111個藥(yao)(yao)品(pin)名(ming)單里,其中(zhong)西(xi)(xi)藥(yao)(yao)類有3種、協(xie)議期內談(tan)判(pan)藥(yao)(yao)品(pin)部分(fen) (一)西(xi)(xi)藥(yao)(yao)類有83種、協(xie)議期內談(tan)判(pan)藥(yao)(yao)品(pin)部分(fen) (二)中(zhong)成藥(yao)(yao)類有8種,競價藥(yao)(yao)品(pin)部分(fen)有17種。
2022醫保(bao)談(tan)判目(mu)錄新(xin)增的74個談(tan)判藥(yao)(yao)品涉(she)及21個臨床組別,其中(zhong)罕見病(bing)用(yong)藥(yao)(yao)7種(zhong),新(xin)冠肺炎治(zhi)療用(yong)藥(yao)(yao)2種(zhong),其他領域(yu)用(yong)藥(yao)(yao)12種(zhong),腫(zhong)瘤用(yong)藥(yao)(yao)18種(zhong),丙肝、艾滋病(bing)等抗毒感(gan)染用(yong)藥(yao)(yao)15種(zhong),高血壓(ya)、糖尿病(bing)、高血脂等慢性病(bing)用(yong)藥(yao)(yao)20種(zhong)。
國(guo)家醫保(bao)局發布了“2021版國(guo)家醫保(bao)目錄”。2021年(nian)共計有117種(zhong)藥品被納入談判范圍,最(zui)...
藥(yao)(yao)智網聯(lian)合(he)中國藥(yao)(yao)業雜志(zhi)社發布了(le)“2022中國藥(yao)(yao)品研發綜合(he)實力百強榜(bang)”。榜(bang)單根據藥(yao)(yao)品受理批準...
全國工(gong)商(shang)(shang)聯醫藥業商(shang)(shang)會發布了“2021年度(du)中國醫藥行業最具影響(xiang)力(li)榜單”。榜單從(cong)營收、利潤、市...
中(zhong)國(guo)董事局網與中(zhong)國(guo)數據研(yan)究中(zhong)心共(gong)同(tong)發布了“2022第八屆(jie)中(zhong)國(guo)最具影響力醫藥企業(ye)百強(qiang)榜(bang)”。榜(bang)...